期刊文献+

HPLC-MS/MS测定比格犬血浆中喹硫平缓释片的药动学特性 被引量:2

Pharmacokinetics of Extended-release Tablets of Quetiapine in Beagle Dogs by HPLC-MS/MS Method
下载PDF
导出
摘要 目的:建立比格犬血浆中喹硫平浓度测定的HPLC-MS/MS定量分析方法,研究喹硫平缓释片在犬体内的药动学特征。方法:采用6只健康成年比格犬随机分成2组,双交叉试验设计进行单剂量给药,并于相应的时间点采集血样,采用HPLC-MS/MS测定比格犬体内的血药浓度并计算主要药动学参数。结果:经统计分析,与普通参比制剂相比,受试缓释制剂的Cmax降低,tmax延迟,t1/2延长。结论:缓释片与普通片相比具有明显的缓释特征。 Objective: To establish an HPLC-MS/MS method for the determination and pharmacokinetic study of quetiapine in Beagle dogs.Methods: Six beagle dogs were randomized into two groups.A two-way crossover study was adopted.Plasma samples were collected at different time points.Plasma concentration of quetiapine was determined by HPLC-MS/MS and pharmacokinetic parameters were calculated.Results: The results indicated that the tmax and t1/2 of extended-release tablets were longer than those of immediate tablets,and the Cmax of extended-release tablets was lower than that of immediate tablets.Conclusion: The test tablets have marked sustained release characters.
出处 《药学与临床研究》 2011年第3期279-281,共3页 Pharmaceutical and Clinical Research
关键词 HPLC-MS/MS 喹硫平 血药浓度 比格犬 药代动力学 HPLC-MS/MS Quetiapine Plasma drug concentration Beagle dog Pharmacokinetics
  • 相关文献

参考文献6

二级参考文献24

  • 1周志凌,程泽能,李坤艳,谢志红,王峰,朱荣华,李焕德.HPLC-MS/ESI法同时检测血浆中4种非典型抗精神病药物[J].中南药学,2004,2(4):205-208. 被引量:13
  • 2Barrett B, M. Holcpek,J. Huclova. Validated HPLC-MS/MS method for determination of quetiapine in human plasma[ J]. Journal of Pharmaceutical and Biomedical Analysis, 2007, (44) :498 -505.
  • 3Kirchherr H, W. N. Kuhn-Velten. Quantitative determination of forty-eight antidepressants and antipsychotics in human serum by HPLC tandem mass-spectrometry: A multi-level, single-sample approach [ J ]. Journal of Chromatography B, 2006, (843) :100 -113.
  • 4Small JG, Hirsch SR, Arvantis LA, et al. Quetiapine in patients with schizophrenia. A high-and low-dose double-blind comparison with placebo[J]. Acta Gen Psychiatr, 1997,54(6) :549.
  • 5Mconville BJ, Arvanitis LA, Thyrum PT, et al. Pharmacokinetics, tolerability and clinical effectiveness of quetiapine fumarate: an open-label trial in psychotic disorders[J]. J Clin Psychiatry,2000,61(4):252.
  • 6Davis PC, Wong J, Gofvert O. Analysis and phamvacokinetics of quetiapine and two metabolites in human plasma using reversed-phase HPLC with ultraviolet and electrochemical detection[J]. J Pharm Bioned Anal,1999,20(1-2) :271.
  • 7HERES S, DAVIS J, MAINO K, et al. Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: An exploratory analysis of head-to-head comparison studies of second-generation antipsychotics [ J ]. Am J Psychiatry, 2006,163(2) : 185-194.
  • 8ESSOCK S M, COVELL N H, JACKSON C T. Antipsychotic drugs and schizophrenia [ J ]. N Eng J Med, 2006,354 ( 3 ) : 298-300.
  • 9KECK P E,STRAWN J R,MCELROY S L Pharmacologic treatment considerations in co-occurring bipolar and anxiety disorders [J]. J Clin Psychiatry,2006,67(Suppl 1 ) : 8-15.
  • 10NEMEROFF C B, KINKEAD B, GOLDSTEIN J. Quetiapine: preclinical studies, pharmacokinetics, drug interactions, and dosing [J]. J Clin Psychiatry,2002,63 (Suppl 13) : 5-11.

共引文献24

同被引文献7

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部